A therapeutic and side effects comparison between domestic type and the similar brand in gastric cancer.

Not Applicable

• Conditions: Gasteric cancer.; Malignant neoplasm of stomach

• Registration Number: IRCT2014061118061N1
• Lead Sponsor: Behin Tamin Rosamed Co.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

inclusion criteria: 1.Patients with gastric cancers, age 18-65, both sex 2.Biopsy and pathology results 3.Filling the consent form through patients or guardian 4.Possible cooperation of patients till the study completed.
exclusion criteria: 1.Ill-informed patient consent for participation in the study 2.Initial CBC disruption, so that lead to the wrong result in lab tests 3.Hypersensitivity to one type of Granolocyte Colony Stimulating Factor 4.History of treated malignancy or co-current malignancy 5.patient may require radiation during treatment 6.recurrent gastric cancer or refractory one that have previously been treated 7.Inappropriate performance status for start or continue treatment 8.Mental illness or depression such that the compliance reduce.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
White Blood Cell / Platlet / Hemoglubin measurement. Timepoint: triweekly. Method of measurement: Blood sample and Cell Blood Count measurement.

Secondary Outcome Measures

Name	Time	Method
CRAMP OF LOWER LIMB , Balance cerebellar. Timepoint: triweekly. Method of measurement: Check up.